1
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe estimates
for 40 countries in 2012. Eur J Cancer. 49:1374–1403. 2013.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Laguna MP, Algaba F, Cadeddu J, Clayman R,
Gill I, Gueglio G, Hohenfellner M, Joyce A, Landman J, Lee B, et
al: Current patterns of presentation and treatment of renal masses
A clinical research office of the endourological society
prospective study. J Endourol. 28:861–170. 2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ljungberg B, Bensalah K, Canfield S,
Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L,
Merseburger AS, et al: EAU guidelines on renal cell carcinoma 2014
update. Eur Urol. 67:913–924. 2015. View Article : Google Scholar : PubMed/NCBI
|
4
|
Ramaswamy K, Kheterpal E, Pham H, Mohan S,
Stifelman M, Taneja S and Huang WC: Significance of pathologic T3a
upstaging in clinical T1 renal masses undergoing nephrectomy. Clin
Genitourin Cancer. 13:344–349. 2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Martinez-Salamanca JI, Huang WC, Millan I,
Bertini R, Bianco FJ, Carballido JA, Ciancio G, Hernández C,
Herranz F, Haferkamp A, et al: Prognostic impact of the 2009
UICC/AJCC TNM staging system for renal cell carcinoma with venous
extension. Eur Urol. 59:120–127. 2011. View Article : Google Scholar : PubMed/NCBI
|
6
|
Thompson RH, Leibovich BC, Cheville JC,
Webster WS, Lohse CM, Kwon ED, Frank I, Zincke H and Blute ML: Is
renal sinus fat invasion the same as perinephric fat invasion for
pT3a renal cell carcinoma. J Urol. 174:1218–1221. 2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Chen K, Lee BL, Huang HH, Tan BY, Lee LS,
Ng LG, Lau W and Yuen JS: Tumor size and Fuhrman grade further
enhance the prognostic impact of perinephric fat invasion and renal
vein extension in T3a staging of renal cell carcinoma. Int J Urol.
24:51–58. 2017. View Article : Google Scholar : PubMed/NCBI
|
8
|
Zhang Z, Yu C, Velet L, Li Y, Jiang L and
Zhou F: The difference in prognosis between renal sinus fat and
perinephric fat invasion for pT3a renal cell carcinoma A
meta-analysis. PLoS One. 11:e01494202016. View Article : Google Scholar : PubMed/NCBI
|
9
|
Mouracade P, Dagenais J, Chavali JS, Kara
O, Nelson RJ, Maurice MJ, Reese J, Rini BI and Kaouk JH:
Perinephric and sinus fat invasion in stage pT3a tumors managed by
partial nephrectomy. Clin Genitourin Cancer. 16:e1077–e1082. 2018.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Margulis V, Tamboli P, Matin SF, Meisner
M, Swanson DA and Wood CG: Location of extrarenal tumor extension
does not impact survival of patients with pT3a renal cell
carcinoma. J Urol. 178:1878–1882. 2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Fuhrman SA, Lasky LC and Limas C:
Prognostic significance of morphologic parameters in renal cell
carcinoma. Am J Surg Pathol. 6:655–663. 1982. View Article : Google Scholar : PubMed/NCBI
|
12
|
Srivastava A, Patel HD, Joice GA,
Semerjian A, Gorin MA, Johnson MH, Allaf ME and Pierorazio PM:
Incidence of T3a up-staging and survival after partial nephrectomy
Size-stratified rates and implications for prognosis. Urol Oncol.
36:12.e7–12.e13. 2018. View Article : Google Scholar
|
13
|
Gorin MA, Ball MW, Pierorazio PM, Tanagho
YS, Bhayani SB, Kaouk JH, Rogers CG, Stifelman MD, Khalifeh A,
Kumar R, et al: Outcomes and predictors of clinical T1 to
pathological T3a tumor up-staging after robotic partial nephrectomy
A multi-institutional analysis. J Urol. 190:1907–1911. 2013.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Weight CJ, Lythgoe C, Unnikrishnan R, Lane
BR, Campbell SC and Fergany AF: Partial nephrectomy does not
compromise survival in patients with pathologic upstaging to
pT2/pT3 or high-grade renal tumors compared with radical
nephrectomy. Urology. 77:1142–1146. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Jeong SH, Kim JK, Park J, Jeon HJ, Yoon
MY, Jeong CW, Ku JH, Kim HH and Kwak C: Pathological T3a upstaging
of clinical T1 renal cell carcinoma outcomes according to surgical
technique and predictors of upstaging. PLoS One. 11:e01661832016.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Bonsib SM, Gibson D, Mhoon M and Greene
GF: Renal sinus involvement in renal cell carcinomas. Am J Surg
Pathol. 24:451–458. 2000. View Article : Google Scholar : PubMed/NCBI
|
17
|
Lee C, You D, Yoo S, Song C, Hong B, Hong
JH, Ahn H and Kim CS: Oncological outcomes of patients with
incidental pathological T3a stage small renal cell carcinoma after
partial nephrectomy. J Cancer Res Clin Oncol. 142:1651–1657. 2016.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Oh JJ, Byun SS, Lee SE, Hong SK, Lee ES,
Kim HH, Kwak C, Ku JH, Jeong CW, Kim YJ, et al: Partial nephrectomy
versus radical nephrectomy for non-metastatic pathological T3a
renal cell carcinoma A multi-institutional comparative analysis.
Int J Urol. 21:352–357. 2014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Park M, Shim M, Kim M, Song C, Kim CS and
Ahn H: Prognostic heterogeneity in T3aN0M0 renal cell carcinoma
according to the site of invasion. Urol Oncol. 35:458.e17–458.e22.
2017. View Article : Google Scholar
|
20
|
Moch H: The WHO/ISUP grading system for
renal carcinoma. Der Pathologe. 37:355–360. 2016.(In German).
View Article : Google Scholar : PubMed/NCBI
|